| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8685350 | Journal of Clinical Neuroscience | 2018 | 6 Pages |
Abstract
Meningioma is a common intracranial and intraspinal neoplasm accounting for 25-30% of all primary neurological tumours. It is associated with high rates of recurrence especially in higher-grade tumours and lesions located at the skull base. Cancer stem cells are increasingly recognised as the origin of cancer and are attributed to loco-regional recurrence, metastasis and treatment resistance. This review presents the accumulating evidence of the presence of tumour stem cells within meningioma and the stem cell markers being used to characterise this putative primitive population within this common tumour.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ganeshwaran Shivapathasundram, Agadha C. Wickremesekera, Swee T. Tan, Tinte Itinteang,